Frank A. Sloan
J. Alexander McMahon Professor Emeritus of Health Policy and Management
Professor Sloan is interested in studying the subjects of health policy and the economics of aging, hospitals, health, pharmaceuticals, and substance abuse. He has received funding from numerous research grants that he earned for studies of which he was the principal investigator. His most recent grants were awarded by the Robert Wood Johnson Foundation, the Center for Disease Control, the Pew Charitable Trust, and the National Institute on Aging. Titles of his projects include, “Why Mature Smokers Do Not Quit,” “Legal and Economic Vulnerabilities of the Master Settlement Agreement,” “Determinants and Cost of Alcohol Abuse Among the Elderly and Near-elderly,” and “Reinsurance Markets and Public Policy.” He received the Investigator Award for his work on the project, “Reoccurring Crises in Medical Malpractice.” Some of his earlier works include the studies entitled, “Policies to Attract Nurses to Underserved Areas,” “The Impact of National Economic Conditions on the Health Care of the Poor-Access,” and “Analysis of Physician Price and Output Decisions.” Professor Sloan’s latest research continues to investigate the trends and repercussions of medical malpractice, physician behavior, and hospital behavior.
Education
- Ph.D., Harvard University 1969
Akushevich, I., A. Yashkin, J. Kravchenko, F. Fang, K. Arbeev, F. Sloan, and A. I. Yashin. “A forecasting model of disease prevalence based on the McKendrick-von Foerster equation..” Math Biosci 311 (May 2019): 31–38. https://doi.org/10.1016/j.mbs.2018.12.017. Full Text
Wang, Yang, and Frank A. Sloan. “Present bias and health..” Journal of Risk and Uncertainty 57, no. 2 (October 25, 2018): 177–98. https://doi.org/10.1007/s11166-018-9289-z. Full Text
Akushevich, Igor, Arseniy P. Yashkin, Julia Kravchenko, Fang Fang, Konstantin Arbeev, Frank Sloan, and Anatoliy I. Yashin. “Identifying the causes of the changes in the prevalence patterns of diabetes in older U.S. adults: A new trend partitioning approach..” J Diabetes Complications 32, no. 4 (April 2018): 362–67. https://doi.org/10.1016/j.jdiacomp.2017.12.014. Full Text
Yashkin, Arseniy P., and Frank Sloan. “Adherence to Guidelines for Screening and Medication Use: Mortality and Onset of Major Macrovascular Complications in Elderly Persons With Diabetes Mellitus..” Journal of Aging and Health 30, no. 4 (April 2018): 503–20. https://doi.org/10.1177/0898264316684270. Full Text
Yashkin, Arseniy P., Julia Kravchenko, Anatoliy I. Yashin, and Frank Sloan. “Mortality and Macrovascular Risk in Elderly With Hypertension and Diabetes: Effect of Intensive Drug Therapy..” Am J Hypertens 31, no. 2 (January 12, 2018): 220–27. https://doi.org/10.1093/ajh/hpx151. Full Text
Gifford, E. J., Lindsey Eldred, and Frank Sloan. “Expanding the Role of Drug Treatment Courts to Prevent Child Maltreatment.” Edited by T. LaLiberte, K. Barry, and Kate Walthour. Cw360 2018, no. Spring (2018).
Pogue, Ye Z., Jahn K. Hakes, and Frank A. Sloan. “Is Major Depression Linked to Alcohol-Impaired Driving?.” Substance Use & Misuse 52, no. 14 (December 2017): 1871–82. https://doi.org/10.1080/10826084.2017.1318147. Full Text
Gifford, E. J., L. M. Eldred, S. A. Mccutchan, and F. A. Sloan. “Prosecution, Conviction, and Deterrence in Child Maltreatment Cases.” Criminal Justice and Behavior 44, no. 10 (October 1, 2017): 1262–80. https://doi.org/10.1177/0093854817727795. Full Text
Acquah, Joseph Kofi, Roshani Dahal, and Frank A. Sloan. “1918 Influenza Pandemic: In Utero Exposure in the United States and Long-Term Impact on Hospitalizations..” American Journal of Public Health 107, no. 9 (September 2017): 1477–83. https://doi.org/10.2105/ajph.2017.303887. Full Text
Yu, Y., and F. A. Sloan. “Trends in elderly health by cohort: Evidence from China.” China Economic Review 44 (July 1, 2017): 282–95. https://doi.org/10.1016/j.chieco.2017.05.001. Full Text
Pages
Edmunds, M., F. A. Sloan, and A. B. Steinwald. Geographic adjustment in medicare payment: Phase II: Implications for access, quality, and efficiency, 2012. https://doi.org/10.17226/13420. Full Text
Edmunds, M., and F. A. Sloan. Geographic adjustment in medicare payment: Phase I: Improving accuracy: Second edition, 2012. https://doi.org/10.17226/13138. Full Text
Sloan, Frank A., and Chee-Ruey Hsieh. Student Solutions Manual to Accompany Health Economics. Vol. 1, 2012.
Sloan, F. A., and C. R. Hsieh. Health Economics. Cambridge, MA: MIT Press, 2012.
Sloan, Frank A., and Hirschel Kasper, eds. Incentives and Choice in Health Care. Vol. 1, 2008.
Sloan, F., and L. Chepke. Medical Malpractice. Cambridge, MA: MIT Press, 2008.
Countries, C. O. C. C. I. L. -. A. M. -. I., B. O. G. Health, and I. O. Medicine. Cancer Control Opportunities in Low- and Middle-Income Countries. Edited by F. A. Sloan and H. Gelband. National Academies Press, 2007.
Sloan, F. A., and C. R. Hsieh. Pharmaceutical innovation: Incentives, competition, and cost-benefit analysis in international perspective, 2007. https://doi.org/10.1017/CBO9780511618871. Full Text
Sloan, F. A., and L. Kozecke. The Law and Economics of Public Health. Now Publishers, 2007. https://doi.org/10.1561/0700000020. Full Text
Sloan, Frank A., Jan Ostermann, Christopher Conover, Jr Donald H Taylor, and Gabriel Picone. The Price of Smoking. Vol. 1, 2006.
Pages
SLOAN, F. A. “The Coming Health Crisis - Who Will Pay for Care for the Aged in the 21st Century - Wolfe,JR.” Journal of Economic Literature. American Economic Association, September 1994.
Sloan, F. A., and S. P. Shah. “Smoking, Economics of.” In Encyclopedia of Health Economics, 316–23, 2014. https://doi.org/10.1016/B978-0-12-375678-7.00313-8. Full Text
Sloan, F. A. “The Economics of Vaccines.” In The Oxford Handbook of the Economics of the Biopharmaceutical Industry, 2012. https://doi.org/10.1093/oxfordhb/9780199742998.013.0017. Full Text
Richman, B., F. Sloan, and D. Grossman. “Fragmentation in Mental Health Benefits and Services: A Preliminary Examination into Consumption and Outcomes.” In The Fragmentation of U.S. Health Care: Causes and Solutions, 2010.
Sloan, F. A., and C. R. Hsieh. “Introduction.” In Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, 1–22, 2007. https://doi.org/10.1017/CBO9780511618871.002. Full Text
Sloan, F. A., and C. R. Hsieh. “Conclusions and policy implications.” In Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, 262–78, 2007. https://doi.org/10.1017/CBO9780511618871.015. Full Text
Sloan, F. A., and C. E. Eesley. “Implementing a public subsidy for vaccines.” In Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective, 107–26, 2007. https://doi.org/10.1017/CBO9780511618871.007. Full Text
Sloan, F. A., and C. E. Eesley. “Governments as insurers in professional and hospital liability insurance markets.” In Medical Malpractice and the U.S. Health Care System, 291–317, 2006. https://doi.org/10.1017/CBO9780511617836.016. Full Text
Sloan, F. A. “Chapter 21 Not-for-profit ownership and hospital behavior,” 1:1141–74, 2000. https://doi.org/10.1016/S1574-0064(00)80034-7. Full Text
Sloan, F. A., and H. Grabowski, eds. “The Impact of Cost-Effectiveness on Public and Private Policies in Health Care: An International Perspective.” Social Science and Medicine. Pergamon Press Ltd., August 1997.
Sloan, F. A., and T. B. Metzloff, eds. “Medical Malpractice: External Influences and Controls.” Law and Contemporary Problems, 1997.
Sloan, F. A., D. H. Taylor, and C. J. Conover. “Hospital conversions - Is the purchase price too low?.” In Changing Hospital Industry, edited by D. M. Cutler, 13–44. UNIV CHICAGO PRESS, 2000.
Day, S., D. S. Grossman, P. Mruthyunjaya, P. P. Lee, and F. A. Sloan. “Reply.” American Journal of Ophthalmology, April 1, 2011. https://doi.org/10.1016/j.ajo.2010.11.033. Full Text
Cook, P. J., J. Ostermann, and F. A. Sloan. “Are Alcohol Excise Taxes Good For Us? Short and Long-Term Effects on Mortality Rates,” n.d. https://doi.org/10.3386/w11138. Full Text Open Access Copy
Selected Grants
Duke KURe Program awarded by National Institutes of Health (Advisor). 2013 to 2023
The Intergeneration Effects of Criminal Justice Policies on Substance Use Crimes awarded by National Institutes of Health (Co-Principal Investigator). 2016 to 2020
The Intergenerational Effects of the Criminal Justice System on Children's Health awarded by (Investigator). 2016 to 2019
The Cost of Bladder Cancer to Medicare awarded by (Principal Investigator). 2018 to 2019
American Journal of Health Economics awarded by (Principal Investigator). 2014 to 2018
Visual Impairment, Treatment and Effects on the Elderly awarded by National Institutes of Health (Principal Investigator). 2001 to 2016
Deterring Drunk Driving: Beliefs, Preferences, Outcomes, and Welfare Implications awarded by National Institutes of Health (Principal Investigator). 2009 to 2016
Effects of drug treatment courts on outcomes of adults and their children awarded by National Institutes of Health (Principal Investigator). 2012 to 2016
Reducing Child Maltreatment Using Legal Interventions awarded by (Principal Investigator). 2013 to 2015
Public Health Law and Child Abuse Prevention awarded by (Principal Investigator). 2013